Found 25 matching trials
A Multiple-Dose Study of Bulevirtide in Participants With Normal and Impaired Renal Function
PHASE1The goals of this study are to compare the amount of study drug, bulevirtid...
Location
Velocity Clinical Research, New Smyrna Beach
Study to Evaluate Switching to Brelovitug for the Treatment of CHD in Participants Receiving Bulevirtide
PHASE2This is a Phase 2b/3, randomized, open-label, multicenter trial evaluating ...
Location
Medical University of Graz
Effectiveness and Clinical Outcomes of Long-term Bulevirtide Monotherapy in Patients With HDV-related Compensated Cirrhosis
N/ARetrospective and prospective, pharmacological, multicentre, non-profit obs...
Location
Foundation IRCCS Ca' Granda Ospedale Maggiore Policlinico, Division of Gastroenterology and Hepatology, Milan, Italy.
Immunological and Virological Characterization of Patients With Chronic HBV-HDV Infection: Outcomes and Response to Bulevirtide Treatment
N/APharmacological, single-center, non-profit observational study.
The presen...
Location
Foundation IRCCS Ca' Granda Ospedale Maggiore Policlinico, Division of Gastroenterology and Hepatology, Milan, Italy.
A Study to Evaluate Tobevibart+Elebsiran Versus Bulevirtide in Chronic HDV Infection
PHASE2A Study to Evaluate Tobevibart+Elebsiran versus Bulevirtide in Chronic HDV ...
Status
Active Not Recruiting
Location
Investigative Site
HEllenic Multicenter ReAl-life CLInical Study for Bulevirtide Therapy in Chronic Hepatitis D: HERACLIS-BLV
N/AThis study aims to assess the efficacy and safety of bulevirtide (BLV) in c...
Location
Department of Gastroenterology, Medical School of National & Kapodistrian University of Athens, General Hospital of Athens "Laiko";
Incidence of Viral Hepatitis D Relapses Upon Discontinuation of Bulevirtide in Patients With Chronic Hepatitis D and Negative HDV RNA
N/AThis observational study will be conducted in patients with chronic co-infe...
Location
Center of Target Therapy
Finite Treatment of Hepatitis Delta With Bulevirtide: Identification of Biomarkers Associated With Sustained Control of HDV Infection
NAFinding biomarkers for stopping bulevirtide treatment of patients with hepa...
Status
Active Not Recruiting
Location
University Hospital Heidelberg; Department of Internal Medicine IV: Gastroenterology, Hepatology, Infectious Diseases, Poisoning
Changes in Bile Acids and Microbiota in Patients With Hepatitis D Treated With Bulvertide
N/AHDV is an RNA virus that infects only in the presence of HBV, affecting abo...
Location
Fondazione Policlinico Universitaro A. Gemelli IRCSS UOC CEMAD
A Trial Evaluating Brelovitug (BJT-778) vs Bulevirtide for the Treatment of Chronic Hepatitis Delta Infection (AZURE-2)
PHASE3This is a Phase 3, global, randomized, open-label, multicenter, trial evalu...
Location
Medical University of Graz